Position in ABBV
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$3,610,782
+$400,195 QoQ
Shares Held
14,349
-2.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#1,525
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Avestar Capital, LLC holds $29,224,901 across 12 Drug Manufacturers - General names. ABBV ranks #3 (12.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,456 | $10,142,380 | |
| 2 | JNJ |
Johnson & Johnson
|
18,732 | $4,757,366 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
14,349 | $3,610,782 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
20,418 | $2,579,610 | |
| 5 | MRK |
Merck & Co., Inc.
|
18,444 | $2,370,054 | |
| 6 | AZN |
Astrazeneca PLC
|
6,836 | $1,296,242 | |
| 7 | AMGN |
Amgen Inc
|
3,577 | $1,295,303 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
16,003 | $922,092 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,610,782 | 14,349 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $3,210,587 | 14,762 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,362,687 | 14,717 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $3,350,846 | 14,472 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $2,917,575 | 15,718 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,832,919 | 13,521 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,286,288 | 12,866 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $2,261,738 | 11,453 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,970,078 | 11,486 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,933,537 | 10,618 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,361,256 | 8,784 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,111,391 | 7,456 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $746,404 | 5,540 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $1,138,061 | 7,141 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $1,034,788 | 6,403 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $767,546 | 5,719 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $871,633 | 5,691 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $832,759 | 5,137 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $561,368 | 4,146 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $456,829 | 4,235 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $925,224 | 8,214 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $984,369 | 9,096 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $875,736 | 8,173 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $659,114 | 7,525 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $970,312 | 9,883 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $568,377 | 7,460 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||